Butantan Institute
Centro de Biotechnologia
Avenue Vital Brasil 1500
Sao Paulo
05504
Tel: 011-5511-3726-1127
Fax: 011-5511-3726-1501
4 articles about Butantan Institute
-
The announcement for the chikungunya vaccine (VLA1553) comes after the U.S. FDA awarded it with a Breakthrough Designation status. Read more about it here.
-
Merck and Co. inked a research collaboration deal with Instituto Butantan, based in Sao Paulo, Brazil, to develop vaccines against dengue virus disease.
-
ViveBio And Butantan Institute Enter Into A Collaboration Agreement For Research In Sample Stabilization Technology To Support Phase III Dengue Vaccine Studies
3/14/2016
-
Pulling a Tooth Could Lead to Tailor-Made Sperm, Butantan Institute Researchers Say
7/9/2008